125 related articles for article (PubMed ID: 9639037)
1. Expression of cytoskeletal proteins differentiates between progressors and non-progressors in treated idiopathic membranous nephropathy.
Tamimi NA; Stevens PE; O'Donnell PL; Strange PG; Muchaneta-Kubara EC; El Nahas AM
Exp Nephrol; 1998; 6(3):217-25. PubMed ID: 9639037
[TBL] [Abstract][Full Text] [Related]
2. Myofibroblasts and the progression of diabetic nephropathy.
Essawy M; Soylemezoglu O; Muchaneta-Kubara EC; Shortland J; Brown CB; el Nahas AM
Nephrol Dial Transplant; 1997 Jan; 12(1):43-50. PubMed ID: 9027772
[TBL] [Abstract][Full Text] [Related]
3. Interstitial myofibroblasts: predictors of progression in membranous nephropathy.
Roberts IS; Burrows C; Shanks JH; Venning M; McWilliam LJ
J Clin Pathol; 1997 Feb; 50(2):123-7. PubMed ID: 9155692
[TBL] [Abstract][Full Text] [Related]
4. Myofibroblasts, predictors of progression of mesangial IgA nephropathy?
Goumenos DS; Brown CB; Shortland J; el Nahas AM
Nephrol Dial Transplant; 1994; 9(10):1418-25. PubMed ID: 7816254
[TBL] [Abstract][Full Text] [Related]
5. Interstitial alpha-smooth muscle actin: a prognostic marker in membranous nephropathy.
Badid C; Desmoulière A; McGregor B; Costa AM; Fouque D; Hadj Aïssa A; Laville M
Clin Nephrol; 1999 Oct; 52(4):210-7. PubMed ID: 10543323
[TBL] [Abstract][Full Text] [Related]
6. Myofibroblast phenotypes expression in experimental renal scarring.
Muchaneta-Kubara EC; el Nahas AM
Nephrol Dial Transplant; 1997 May; 12(5):904-15. PubMed ID: 9175042
[TBL] [Abstract][Full Text] [Related]
7. The expression of cytoskeletal proteins (alpha-SMA, vimentin, desmin) in kidney tissue: a comparison of fetal, normal kidneys, and glomerulonephritis.
Gonlusen G; Ergin M; Paydaş S; Tunali N
Int Urol Nephrol; 2001; 33(2):299-305. PubMed ID: 12092643
[TBL] [Abstract][Full Text] [Related]
8. Correlations of tissue macrophages and cytoskeletal protein expression with renal fibrosis in patients with diabetes mellitus.
Yonemoto S; Machiguchi T; Nomura K; Minakata T; Nanno M; Yoshida H
Clin Exp Nephrol; 2006 Sep; 10(3):186-92. PubMed ID: 17009076
[TBL] [Abstract][Full Text] [Related]
9. A quantitative study of the interstitial expression of alpha-smooth muscle actin (alpha-SMA) in idiopathic membranous glomerulonephritis and minimal change disease in adults.
Danilewicz M; Wagrowska-Danilewicz M; Antoszczyk L
Pol J Pathol; 2000; 51(1):37-43. PubMed ID: 10833902
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy.
Mezzano SA; Droguett MA; Burgos ME; Ardiles LG; Aros CA; Caorsi I; Egido J
Kidney Int; 2000 Jan; 57(1):147-58. PubMed ID: 10620196
[TBL] [Abstract][Full Text] [Related]
11. The role of myofibroblasts and interstitial fibrosis in the progression of membranous nephropathy.
Rocha KB; Soares VA; Viero RM
Ren Fail; 2004 Jul; 26(4):445-51. PubMed ID: 15462114
[TBL] [Abstract][Full Text] [Related]
12. Cytoskeletal protein expression and regenerative markers in schistosomal nephropathy.
El-Koraie AF; Baddour NM; Adam AG; El-Kashef EH; El Nahas AM
Nephrol Dial Transplant; 2002 May; 17(5):803-12. PubMed ID: 11981067
[TBL] [Abstract][Full Text] [Related]
13. Myofibroblasts and the progression of crescentic glomerulonephritis.
Goumenos D; Tsomi K; Iatrou C; Oldroyd S; Sungur A; Papaioannides D; Moustakas G; Ziroyannis P; Mountokalakis T; El Nahas AM
Nephrol Dial Transplant; 1998 Jul; 13(7):1652-61. PubMed ID: 9681707
[TBL] [Abstract][Full Text] [Related]
14. Myofibroblasts and the progression of experimental glomerulonephritis.
Zhang G; Moorhead PJ; el Nahas AM
Exp Nephrol; 1995; 3(5):308-18. PubMed ID: 7583053
[TBL] [Abstract][Full Text] [Related]
15. Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy.
Sanai T; Sobka T; Johnson T; el-Essawy M; Muchaneta-Kubara EC; Ben Gharbia O; el Oldroyd S; Nahas AM
Diabetologia; 2000 Jan; 43(1):91-100. PubMed ID: 10663221
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of tubular epithelial cells and vascular endothelial cells in glomerulonephritis.
Bob F; Gluhovschi G; Herman D; Petrica L; Bozdog G; Gluhovschi C; Velciov S; Gadalean F; Timar R; Potencz E; Dema A; Schiller A
Ren Fail; 2014 Sep; 36(8):1208-14. PubMed ID: 24946133
[TBL] [Abstract][Full Text] [Related]
17. Renal pathology in idiopathic membranous nephropathy: a new perspective.
Troyanov S; Roasio L; Pandes M; Herzenberg AM; Cattran DC
Kidney Int; 2006 May; 69(9):1641-8. PubMed ID: 16572119
[TBL] [Abstract][Full Text] [Related]
18. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A; Hill GS; Montseny JJ; Meyrier A
Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
[TBL] [Abstract][Full Text] [Related]
19. The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy.
Ranieri E; Gesualdo L; Grandaliano G; Maiorano E; Schena FP
J Nephrol; 2001; 14(4):253-62. PubMed ID: 11506247
[TBL] [Abstract][Full Text] [Related]
20. Interstitial expression of alpha-SMA: an early marker of chronic renal allograft dysfunction.
Badid C; Desmouliere A; Babici D; Hadj-Aissa A; McGregor B; Lefrancois N; Touraine JL; Laville M
Nephrol Dial Transplant; 2002 Nov; 17(11):1993-8. PubMed ID: 12401859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
